BIO

Dr David Rabbolini is a haematologist who specialises in conditions related to bleeding and blood clotting.

Dr David John Rabbolini

BSc MBBCh PhD FRACP FRCPA

David is a haematologist who specialises in conditions related to bleeding and blood clotting.

He has trained and practiced in tertiary centres of excellence in Australia and the UK (Oxford), as well as in rural and regional centres in South Africa and Australia. Having obtained his PhD (Sydney) exploring rare bleeding disorders and through his continued involvement in clinical and translational research, David continues to play an active role in the development of his field.

David believes that optimal health can be achieved through simple measures that include diet, exercise, and spiritual practice. In the setting of illness he believes in the importance of an individualised and integrated approach using the best available cutting-edge diagnostics and contemporary medicines. David places an emphasis on informed and shared decision making to achieve the best outcomes for his patients.

AFFILIATIONS

HONORARY SENIOR LECTURER

The Kolling Institute
Faculty of Medicine and Health
The University of Sydney

CO-LEAD


The Sydney Platelet Group
(research collaborative)

SPEAKER CONTRIBUTIONS

SPEAKER CONTRIBUTIONS

Dr Rabbolini’s experience has been recognised by his peers, and he has been an invited speaker at 13 national and international (UK, Spain and Kenya) conferences and workshops in the last 5 years and has moderated an International Society of Thrombosis and Haemostasis (ISTH) led webinar on Genetics in haemostasis and thrombosis. Dr Rabbolini is actively engaged in research and education and his contributions have been recognised through invitations on a national and international stage. Notable speaker roles have included:

RESEARCH & PUBLICATIONS

RESEARCH & PUBLICATIONS

David has been successful in contributing to the field through a total of 26 publications (senior author 4; first author 11; second author 10 and middle author 1). Collectively, his work has focused on improving the diagnosis and management of platelet related bleeding disorders through descriptions of his experience using genetic sequencing technologies to diagnose these disorders, and via reports detailing phenotypic characteristics and pathophysiological mechanisms of specific disorders caused by pathological genetic variants in genes associated with bleeding. For further information, view Research Interests and Publications.